Fortrea Holdings Inc. (FTRE)
Automate Your Wheel Strategy on FTRE
With Tiblio's Option Bot, you can configure your own wheel strategy including FTRE - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol FTRE
- Rev/Share 30.0403
- Book/Share 9.6063
- PB 0.533
- Debt/Equity 1.4978
- CurrentRatio 0.9712
- ROIC -0.2831
- MktCap 463360000.0
- FreeCF/Share 1.623
- PFCF 3.1934
- PE -0.5765
- Debt/Assets 0.4121
- DivYield 0
- ROE -0.6113
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | FTRE | Truist | -- | Hold | -- | $7 | May 2, 2025 |
| Downgrade | FTRE | Barclays | Equal Weight | Underweight | -- | $6 | April 10, 2025 |
| Downgrade | FTRE | Citigroup | Buy | Neutral | $30 | $23 | Dec. 11, 2024 |
| Downgrade | FTRE | Robert W. Baird | Outperform | Neutral | $28 | $25 | Dec. 6, 2024 |
| Downgrade | FTRE | Jefferies | Buy | Hold | $25 | $21 | Sept. 25, 2024 |
News
Fortrea Holdings Inc. (FTRE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Published: March 05, 2025 by: Business Wire
Sentiment: Neutral
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN FORTREA HOLDINGS INC. (FTRE), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights.
Read More
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Published: March 04, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Fortrea Holdings Inc. (“Fortrea” or the “Company”) (NASDAQ: FTRE) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FORTREA HOLDINGS INC. (FTRE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On March 3, 2025, Fortrea released its fourth quarter and ful.
Read More
Fortrea Holdings Inc. (FTRE) Q4 2024 Earnings Call Transcript
Published: March 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Fortrea Holdings Inc. (NASDAQ:FTRE ) Q4 2024 Earnings Call March 3, 2025 9:00 AM ET Company Participants Hima Inguva - Head, Investor Relations and Corporate Development Tom Pike - Chief Executive Officer Jill McConnell - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Justin Bowers - DB David Windley - Jefferies Elizabeth Anderson - Evercore Luke Sergott - Barclays Eric Coldwell - Baird Max Smock - William Blair Will Ortmayer - Goldman Sachs Charles Rhyee - TD Cowen Michael Ryskin - Bank of America Operator Ladies and gentlemen, thank you for standing by, and welcome to Fortrea Fourth …
Read More
Fortrea to Add Erin L. Russell to Board of Directors
Published: February 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
DURHAM, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that it will appoint Erin L.
Read More
Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research
Published: February 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
Fortrea to Sponsor SCRS' Collaborate Forward Working Group, Encouraging Collaboration for More Efficient Clinical Trials Fortrea to Sponsor SCRS' Collaborate Forward Working Group, Encouraging Collaboration for More Efficient Clinical Trials
Read More
About Fortrea Holdings Inc. (FTRE)
- IPO Date 2023-06-20
- Website https://www.fortrea.com
- Industry Biotechnology
- CEO Mr. Peter M. Neupert
- Employees 15000